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Abstract This study investigates whether nitric oxide (NO) 
release from linsidomine (SIN-1), the active metabolite of the 
antianginal drug molsidomine, is light sensitive. A 9-h irradiation 
with polychromatic visible light increased the formation of nitrite 
(NO index metabolite) from SIN-1 (1 mM) by 61% as compared 
to control samples incubated in the dark. Under the same 
conditions (9-h irradiation) the concentration of oxygen 
decreased to 2% of control. However, oxygen consumption was 
substantially reduced when light was excluded (35% recovery 
after 9 h). These results show that irradiation with visible light 
markedly enhances the oxygen-dependent NO release from SIN-
1. Thus, sydnonimines appear to be suitable model compounds 
for the development of photoactivatable N O donors. 
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1. Introduction 
Organic nitrates have remained useful agents for the man-
agement of myocardial ischemia and its principal symptom 
angina pectoris since they were introduced into clinical ther-
apy over a hundred years ago. The cellular mechanism under-
lying their antianginal action involves conversion of these 
compounds into the nitric oxide (NO) free radical, which 
then stimulates the vasodilatory second messenger cyclic 
G M P (for review see [1]). Thus, organic nitrates have to be 
classified as prodrugs releasing the pharmacologically active 
metabolite N O . In the case of the nitric acid esters, previous 
studies suggest an enzymatic process to be responsible for the 
bioactivation of, i.e. N O release from, these compounds [2,3]. 
In contrast to that, sodium nitroprusside and sydnonimines 
have long been considered to be purely spontaneous N O do-
nors which decompose in aqueous solutions generating N O 
without requiring enzymatic bioactivation or other co-factors. 
Recently, however, it has been shown that in vitro sodium 
nitroprusside releases N O only in the presence of light where-
as no formation of N O was detected in the dark [4]. These 
observations have raised questions as to the ' spontaneous ' 
character of N O formation from sodium nitroprusside in 
vivo, i.e. in vascular tissue, where light is absent [4]. Linsido-
mine (SIN-1), the active metabolite of molsidomine, is also 
considered a spontaneous donor of N O and frequently used 
to provide prophylaxis against anginal episodes without caus-
ing tolerance even during long-term treatment. 
In the present study the effect of light on N O formation 
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from SIN-1 is investigated and compared to the photochem-
ical activation of sodium nitroprusside under the same con-
ditions. 
2. Materials and methods 
2.1. Materials 
A tungsten lamp (wolfram, 40 W) was used to generate visible, 
polychromatic light. By using an irradiation chamber, which was lined 
with aluminum foil in the interior, radiation was spread evenly (light 
intensity: 3500 lux). Incubations were carried out at 25°C in all-glass 
volumetric flasks. Flasks were wrapped with aluminum foil to exclude 
light and perform incubations in the dark. The temperature in the 
chamber and in the samples was closely monitored and remained 
constant during irradiation. Thus, a temperature-dependent effect on 
NO release from SIN-1 under the chosen conditions can be excluded. 
NO donors were dissolved in air saturated phosphate buffer (Soren-
sen, 67 mM, pH = 7.6). The final volume of irradiated solutions during 
assessment of NO release was 5 ml. 
SIN-1 was provided by Hoechst AG (Frankfurt, Germany). So-
dium nitroprusside, sulfanilamide and naphthylethylenediamine were 
obtained from Sigma. All other reagents were of analytical grade or 
were purified to HPLC purity prior to use. 
2.2. Measurement of nitrite/nitrate 
NO generation was measured by assessing the amount of the stable 
NO metabolite nitrite. Nitrite was quantitated colorimetrically via the 
Griess reaction as described previously [5]. 60 ul sample aliquots were 
incubated for 10 min with 80 ul of 1% sulfanilamide in 4 N HC1 at 
room temperature. After adding 60 ul of 1% naphthylethylenediamine 
in methanol, incubation was continued for another 10 min. Nitrite 
concentration proportional to OD54o was determined using a micro-
plate reader (BIO-TEK, EL 311s), with reference to a standard curve. 
The simultaneous determination of nitrite and nitrate ions was per-
formed using an HPLC method described previously including anion 
exchange chromatography and photometric detection at 200 nm [6,7]. 
Prior to sample injection, remaining sydnonimines and their degrada-
tion products, which interfered with the measurement of nitrite/ni-
trate, were removed by solid phase extraction using cation exchange 
columns (Adsorbex SCX, Merck, Darmstadt, FRG). 
2.3. Measurement of oxygen consumption 
Oxygen consumption was assessed polarographically using a Clark 
electrode [8,9]. Air saturated phosphate buffer (Sorensen, 67 mM, 
pH = 7.6) was filled into a closed all-glass system and maintained at 
25°C under continuous stirring. Freshly prepared solutions of NO 
donors were injected and oxygen consumption was recorded. 
3. Results 
After a 9-h incubation of SIN-1 (1 m M ) in the absence of 
light, a concentration of 117 u,M nitrite was measured with 
the Griess assay. Under the same conditions, irradiation with 
light increased nitrite formation from SIN-1 by 6 1 % to 188 
u M (not shown). Similar results were obtained with the 
H P L C method showing that irradiation with light led to an 
increased formation of both nitrite and nitrate in a solution 
containing SIN-1 (Fig. 1). 
Sodium nitroprusside (1 m M ) released 70.7 u M nitrite after 
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Fig. J . Effect of irradiation with visible light on the formation of nitrite and nitrate from 1 mM SIN-1 (HPLC). The data are means! S E M 
of n-5 observations Irradiated samples (-Might) vs. samples kept in the dark (-light) were found to be significantly different from time point 
5.0 h to time point 10.0 h (P< 0.05, two-tailed r-test). 
a 9-h irradiation but no detectable amounts of nitrite were 
generated in the dark (Fig. 2). 
Since NO formation from SIN-1 is an oxygen consuming 
process we further studied the light dependence of the oxygen 
consumption by SIN-1. The oxygen concentration in a 1 mM 
solution of SIN-1 decreased to 2% of control during a 9-h 
exposure to light (100% equals 250 uM oxygen at time point 
zero, Fig. 3). Under the same conditions, oxygen consumption 
was substantially reduced when light was excluded (35% re-
covery after 9 h, Fig. 3). 
4. Discussion 
The present study demonstrates that NO release from SIN-
1 in vitro is markedly enhanced by visible light. In aqueous 
oxygen containing solutions NO is quickly oxidized to nitrite 
and nitrate (via hydrolysis of intermediate N 2 0 4 ) , which can 
both be used as stable index metabolites of NO [5,8]. In the 
case of SIN-1, nitrate formation may also involve intermedi-
ate generation of peroxynitrite from NO and superoxide [8]. 
Using the colorimetric Griess reaction we found a light-in-
duced increase in nitrite formation from SIN-1. Similar results 
were obtained with an HPLC method showing that irradia-
tion with light led to an increased formation of both nitrite 
and nitrate in a solution containing SIN-1. These results dem-
onstrate that the light-induced increase in nitrite ions meas-
ured by the Griess reaction is actually due to increased gen-
eration of NO from SIN-1 and not caused by changes in the 
subsequent oxidation of NO (nitrite/nitrate ratio) such as in-
creased nitrite and reduced nitrate formation. This is sup-
ported by our observation that oxygen consumption, which 
triggers NO release from SIN-1 [8,9], was also enhanced in the 
presence of light. Interestingly, oxygen concentration during 
SIN-1 breakdown fell to close to zero after about 5 h whereas 
NO formation continued. However, this apparent discrepancy 
may be explained by recent findings that after the consump-
tion of oxygen, NO formation within a SIN-1 solution con-
tinues either via reaction of remaining unmetabolized SIN-1 
with oxidants other than oxygen or from intermediate nitro-
gen oxide species with a longer half-life than NO itself [8]. 
Sodium nitroprusside, another spontaneous NO donor, was 
found to release no nitrite at all when incubated in the dark, 
which is in line with a previous study [4]. In contrast, SIN-1 is 
able to generate NO in the dark but appears to share with 
sodium nitroprusside the sensitivity to photoactivation. 
Although photolysis itself probably makes no physiological 
contribution, a modulation by visible light of NO release 
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Fig. 2 Effect of irradiation with visible light on the formation of nitrite from 1 mM sodium nitroprusside (Griess reaction). The data are 
means + S.E.M. of n - 5 observations. Irradiated samples (+light) vs. samples kept in the dark (-light) were found to be significantly different 
for every time point shown (P< 0.05, two-tailed Mest). 
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Fig. 3. Effect of irradiation with visible light on oxygen consump-
tion by 1 mM SIN-1. The data are means ± S.E.M. of n = 5 observa-
tions. Arrows mark the addition of sodium dithionite (10 mM) in 
order to stop the reaction and control for remaining oxygen content 
( < 3%) under equilibrium conditions. Irradiated samples (+light) vs. 
samples kept in the dark (—light) were found to be significantly dif-
ferent from time point 2 h (P < 0.05, two-tailed f-test). 
of the respective compound in vivo, i.e. in vitro visible light 
may substitute for the reduction of activation energy during 
enzymatic catalysis [4,10]. Thus, our findings suggest that in 
addition to spontaneous NO release, enzymatic or other en-
ergy yielding processes may contribute to bioactivation of 
SIN-1 in vivo. 
Interestingly, Venturini and co-workers [10] reported a pho-
toactivatable store of endogenous NO in vascular smooth 
muscle suggesting similarities in the release mechanism of 
NO containing drugs and physiological NO stores (endothe-
lium-derived relaxing factor). Iron-sulfur cluster nitrosyls and 
other NO containing compounds have also been shown to 
release NO via photoactivation [11,12]. According to our find-
ings, SIN-1 has to be added to the list of photosensitive NO 
donors. Photosensitivity of NO donors developed in the fu-
ture may open up the possibility to confine NO generation 
from these compounds and subsequent pharmacological ef-
fects (e.g. vasodilation) to distinct organs or tissues by expos-
ing the latter to laser light or other focused energy sources. 
Photosensitive NO generation could also be an approach to 
exploit the cytotoxic effects of NO at high concentrations, e.g. 
in tumor therapy, and to prevent or limit NO induced damage 
to surrounding healthy tissue. Thus, our results may explain 
very recent findings by Wood et al. [13] demonstrating that 
SIN-1 given immediately before irradiation with X-rays in-
creases tumor cell killing in mice 2^1-fold over that for X-
rays alone. 
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